Item 2.01 Completion of Acquisition or Disposition of Assets

On December 30, 2019, Hologic, Inc. (the "Company") completed its previously announced sale of its Cynosure medical aesthetics business (the "Transaction") pursuant to the Securities Purchase Agreement, dated November 20, 2019, by and among the Company, Hologic Holdings Limited, a wholly owned subsidiary of the Company, and Lotus Buyer, Inc., a Delaware corporation and an affiliate of a fund managed by affiliates of Clayton Dubilier & Rice, LLC ("Purchaser"). After estimated closing adjustments, Hologic received net cash proceeds of approximately $142 million. The purchase price remains subject to adjustment upon finalization pursuant to the terms of the Securities Purchase Agreement.

Item 7.01 Regulation FD Disclosure

On December 30, 2019, the Company issued a press release announcing the completion of the Transaction. A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated into this Item 7.01 by reference.

The information furnished in this Item 7.01 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of such section, nor shall such information be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.



(b)  Pro Forma Financial Information
The following unaudited pro forma condensed combined financial information
related to the Disposition is attached as Exhibit 99.2 hereto and is
incorporated by reference herein:
(i)   Unaudited Pro Forma Condensed Consolidated Balance Sheet as of September
28, 2019.
(ii)  Unaudited Pro Forma Condensed Consolidated Statement of Income for the
Year Ended September 28, 2019.

(d)  Exhibits
Exhibit No.      Description
99.1               Press Release issued by Hologic, Inc. on December 30, 2019
99.2               Unaudited Pro Forma Condensed Consolidated Financial Information.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses